Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MBBS IV - Supplementary Courses > JC Block C - Clinical Oncology Teaching Clinic I and II (all) > Flashcards

JC Block C - Clinical Oncology Teaching Clinic I and II (all) Flashcards

1
Q

Hallmarks of cancer

A 
o Sustaining proliferative signaling
o Evading growth suppressors
o Activating invasion and metastasis
o Enabling replicative immortality
o Inducing angiogenesis
o Resisting cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Reasons of growing cancer incidence

A

 Aging population (exposed to more risk factors; decreased immunity)

 Westernised lifestyle: high fatty intake, sedentary lifestyle without exercise

 Unfavourable habits: smoking, alcoholism, unprotected sun-tanning, unsafe sex (cervical cancer, HPV-associated oropharyngeal
cancer)

 Improved cancer screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 leading behavioral and dietary risks of cancer development

A
  1. High body mass index
  2. Low fruit and vegetable intake
  3. Lack of physical activity
  4. Tobacco use (= most important risk factor for cancer)
  5. Alcohol use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline WHO’s Comprehensive cancer control strategy & action plan

A

Aims:
o Reduce cancer incidence and mortality
o Improve quality of life of cancer patients and their families

Plan:
o Prevention (e.g. HPV vaccine)
o Early detection (screen high-risk group)
o Diagnosis and treatment
o Rehabilitation
o Palliative care, survivorship:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Incidence rate of cancer in HK

Mortality rate

A

1 in 4 men and 1 in 5 women will develop cancer before age of 75

Median age at diagnosis of cancer:
 68 years in men
 62 years in women

(~1/3) of all deaths
1 in 9 men and 1 in 15 women will die from cancer before age of 75

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common cancers in male and female in HK

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cancers with increasing incidence rate in HK

A

o Female: breast, corpus uteri, pancreas

o Male: prostate, kidney (RCC), non-Hodgkin lymphoma, thyroid, pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Top 5 cancer in incidence and mortality rate in HK (both sex)

A

Incidence:
- Colorectal, Lung, Breast, Prostate, Liver

Mortality:
- Lung, colorectal, liver, breast, pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effect of cancer growth

A 
Local effects: 
o Mechanical (e.g. bone, spine collapse)
o Disturbance of functions:
 Anatomical (e.g. metastasis to humerus)
 Physiological
 Irritation/infiltration of nerves
 Hormonal disturbance

Systemic constitutional effects

Paraneoplastic manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List examples of paraneoplastic manifestations

A

 Dermatomyositis (e.g. breast, lung, NPC)

 Lambert-Eaton myasthenic syndrome (LEMS) (e.g. small cell lung cancer)

 Hypercalcaemia of malignancy (e.g. SCC lung, breast, lymphoma, prostate (sic))

 SIADH (e.g. small cell lung cancer (oat cell), breast, pancreatic)

 Cushingnoid features (etopic ACTH production) (e.g. small cell lung cancer)

 Hypoglycaemia (e.g. HCC)

 Polycythaemia (e.g. RCC: erythropoietin production)

 Vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of finger clubbing

A

 Respiratory system: CA lung, fibrosis, bronchiectasis, lung abscess

 Cardiovascular system: infective endocarditis, cyanotic heart disease

 GI: liver cirrhosis, inflammatory bowel disease

 Thyrotoxicosis (traditionally called pseudoclubbing) due to soft tissue proliferation

 Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Key presenting features of colorectal CA

A

 Per rectal bleeding
 Constipation/ change in bowel habit
 Tenesmus (= most specific: tumor in sigmoid/ rectum)
 Abdominal pain
 Abdominal distension: ascites, IO or liver met.
 Other local symptoms (e.g. hematochezia, passing mucus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Workup investigations for colorectal CA

A

 Proctoscopy/ colonoscopy – biopsy of lesion

 AXR: IO features

  • Proximal dilatation of bowel
  • Multiple air-fluid level
  • Perforation

 CT abdomen and pelvis (for staging, metastasis, complications)

  • Obstructing lesion (white solid arrow)/ mural thickening of rectosigmoid junction
  • Liver met.
  • Ascites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Workup investigation for rectal CA

A

 Endorectal US (for local staging: depth of invasion)

 Pelvic MRI:
o Mural thickening
o Enlarged mesorectal lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ddx colorectal cancer

A 
Differential diagnoses – benign:
 Benign polyp (can be pre-malignant)
 Haemorrhoid
 Inflammatory bowel diseases
 Infective colitis
 Diverticulitis +/- abscess

 Adhesions
 Paralytic ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Key presenting features of lung cancer

A

 Chronic cough, no regression

 Haemoptysis

 Shortness of breath, new wheezing, recurrent chest infection (tumor obstruction)

 Hoarseness

 Lower neck mass

(pleuritic chest pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

3 syndromes a/w lung cancer **

A

Superior vena cava syndrome* (SVCO)
 Dilated veins at neck and chest wall, facial & neck swelling (including lips), edematous arms and hands, dyspnea

Horner syndrome* (compression of sympathetic trunk usually at C7-T1)
 4 major features: partial ptosis, miosis, anhidrosis, enophthalmus

Pancoast syndrome (invades adjacent ribs & vertebrae)
- Brachial plexus:
o Severe pain at shoulder radiating toward axilla, scapula, ulnar aspect of hand
o Atrophy of small muscles of hand
- Cervical sympathetic nerves (Stellate ganglion): Horner’s syndrome

18
Q

Paraneoplastic syndromes of lung cancer

A

 SIADH (hyponatremia)

 Cushing syndrome (ectopic ACTH production in small cell lung cancer)

 Lambert-Eaton syndrome* (production of IgG antibodies binding to voltage-gated Ca2+ channels):
o Proximal muscle weakness
o Autonomic disturbance

 Hypercalcaemia (PTHrP)

 Hypertrophic osteoarthropathy

 Cerebellar ataxia

 Peripheral neuropathy

19
Q

Workup investigations for lung cancer

A

CXR

CT thorax

Sputum cytology, C/ST, AFB (if suspect carcinomatosis or TB)

Biopsy:
 CT or EBUS (endobronchial US) guided
 Bronchoscopy
 Mediastinoscopy

Staging Ix: TNM/ limited or extensive staging

Metastatic:
 CT/ MRI brain for distant metastasis
 PET-CT
 Blood tests: LFT, RFT (includes creatinine, urea, K+ , Na+), Ca2+, CEA (tumor marker for adenocarcinoma), LDH (prognosis)

20
Q

Ddx lung cancer

21
Q

Key features of breast cancer

A 
 Breast lump, Fungating mass
 Skin changes (redness/ dimpling)
 Nipple retraction
 Nipple discharge
 Axillary/ neck swelling
 Upper limb – lymphedema due to LN met. or radiotherapy

 Signs of metastasis (bone, liver, lung, brain)

22
Q

Workup investigations for breast cancer

A

 Mammogram/ USG
 MRI breast
 FNAC/ core biopsy

23
Q

Ddx breast cancer

24
Q

Prostate cancer

Key presenting features

A

Common presenting symptoms:
 Problem in passing urine (but seldom painful)
 Haematuria
 Haemaspermia
 Bone metastases: Bone pain, spinal cord compression, hypercalcemia S/S

Clinical signs:
 DRE: hard prostatic nodules, loss of middle sulcus
 Bony tenderness (cord compression in advanced cases)

25
Q

Workup investigations for prostate cancer

A

 Tumour marker: PSA

 MRI pelvis

  • Prostate cancer (e.g. involving peripheral, transition zone)
  • Extracapsular spread, e.g. invasion to seminal vesicles, neurovascular bundle, anterior wall of rectum
  • Lymph nodes

 Transrectal ultrasound (TRUS) guided biopsy

 MRI spine

26
Q

Ddx prostate cancer

A

 Benign: benign prostate hyperplasia

 Malignant: direct invasion from bladder or rectum cancers

27
Q

Liver cancer

Key presenting features

A

Presentation
 Abdominal distension (hepatomegaly, ascites)
 Abdominal pain especially at RUQ
 Jaundice, HE, Hypoglycaemia

Signs:
 Jaundice
 Signs of chronic liver diseases(clubbing, palmar erythema, Dupuytren’s contracture, flapping tremor, spider naevi, gynaecomastia, testicular atrophy)
 Lower limb edema
 Hepatomegaly – hard, irregular
 Ascites
 Splenomegaly
28
Q

Workup investigations for liver cancer

A

 HBV and HCV serology
 Tumor marker: alpha fetoprotein for HCC
 Imaging:
Ultrasound liver
Triphasic CT scan – if hepatocellular carcinoma
CT angiography
MRI liver

29
Q

Ddx HCC

30
Q

NPC

Risk factors

A

EBV infection

genetic predisposition : HLA A2 + BW 46

Environmental factors: salted fish (nitrosamines), alcohol, poor oral hygiene

31
Q

NPC Key presenting features

A

Neck mass (LN involvement)

Nasal obstruction, bleeding, epistaxis, post-nasal drip, blood-stained saliva, discharge

Aural (tinnitus, deafness, pain, discharge) due to blockage of Eustachian tube:

Headache

Cranial nerve palsy spread further up to cavernous sinus - Compress on CN III, IV, V1, V2, VI

Dermatomyositis* (paraneoplastic)

32
Q

Workup investigations for NPC

A

 Tumour marker: EBV-DNA, IgA anti-EBV

 Nasopharyngoscopy & biopsy at fossa of Rosenmuller

 MRI with gadolinium from skull base to clavicle, i.e. nasopharyngeal & cervical regions, and/or CT with contrast

 FDG-PET/CT for systemic workup + supplement locoregional assessment

33
Q

Prognosis of NPC

A

Prognosis – survival by stage (5-year):
 I: 100% (very good)
 II: 95% (very good)
 III: 90% (regional LN; amenable to radical chemoirradiation)

 IVA: 67%
 IVB: 68%
 IVC: 18%

34
Q

General Constitutional and metastatic symptoms of all cancers

35
Q

Modalities of pathological diagnosis of cancer

A

Modalities:
 Cytology
 Histopathology
 Liquid-based biopsy (blood, pleural effusion, pericardial effusion) for circulating tumour cells or circulating tumour DNA
 Biological and genetic characteristics: e.g. ER/ PR/ EGFR/ ALK…etc

36
Q

Examples of hormonal therapy for cancer treatment

Examples of immunotherapy

A

Hormonal:
o Breast cancer: tamoxifen, aromatase inhibitors
o Prostate cancer: abiraterone
o Neuroendocrine tumors: octreotide

Immuno:
o Anti-PD-1: nivolumab, pembrolizumab, pidilizumab
o Anti-PD-L1: atezolizumab, durvalumab, avelumab

37
Q

Key presenting features of gastric cancer

A

Epigastric discomfort/ pain - “indigestion”, dyspepsia, early satiety

Obstructive symptoms: vomiting, dysphagia

 Melena, coffee ground vomiting
 Systemic: anemia, weight loss

38
Q

Workup investigations for gastric cancer

A

Endoscopy: OGD and biopsy

CT abdomen and pelvis: metastasis, LN involvement, ascites, adnexal masses, complications e.g. GOO, Perforation

Barium meal (e.g. nodular, markedly thickened folds)

39
Q

Ddx gastric cancer

40
Q

Skin cancer

Key presenting features
Most common types

A

Presenting symptoms:
 Lump, nodules
 Non-healing ulcer
 Bleeding, pain (late stage)

Different histology:
 Basal cell carcinoma
 Squamous cell carcinoma
 Merkel cell carcinoma
 Cutaneous lymphoma
 Kaposi’s sarcoma
 Angiosarcoma
 Dermatofibroma protuberans
41
Q

Ddx skin cancer

MBBS IV - Supplementary Courses (54 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions